Page 1 | Search Results | Blood | American Society of Hematology

1-5 of 5

Sort by

Sort Order Select

Journal Articles

Phenotypic and Proliferative Analysis of T Cell and Monocyte Populations in Patients with Intermediate/High/Very High-Risk MDS Compared to Age-Matched Healthy Donors

Hannah Fields, Valentina Ferrari, BA, Alison Tarke, BS, Randy Guo-Shi Tsai, BS, BA, Timothy Luger, Colin McCarthy, BS, Ruifeng Chen, Xinlian Zhang, Thomas A Lane, MD, Antonella Vitiello, Dr. Pharm., Rafael Bejar, MD PhD, Tiffany N Tanaka, MD

Blood (2020) 136 (Supplement 1): 25–26.

https://doi.org/10.1182/blood-2020-142038

Published: 2020

Journal Articles

T Cell Activation By OKT3 Is a Function of the Percent Monocytes in PBMC of Healthy Donors and MDS Patients

Alison Tarke, Valentina Ferrari, BA, Hannah Fields, Luca Ferrari, Franco Ferrari, PhD, Tiffany N Tanaka, MD, Rafael Bejar, MD PhD, Antonella Vitiello, Dr. Pharm., Thomas A Lane, MD

Blood (2019) 134 (Supplement_1): 4870.

https://doi.org/10.1182/blood-2019-131474

Published: 2019

Journal Articles

A Phase 1 Clinical Trial of Personalized Adoptive Cellular Therapy Targeting Myelodysplastic Syndrome (MDS) Stem Cell Neoantigens (PACTN)

Valentina Ferrari, Tiffany N Tanaka, MD, Alison Tarke, Hanna Fields, Luca Ferrari, Alex Ni, Franco Ferrari, PhD, John Warner, PhD, Theresa Jochelson, Rafael Bejar, MD PhD, Antonella Vitiello, Dr. Pharm., Thomas A Lane, MD

Blood (2018) 132 (Supplement 1): 4373.

https://doi.org/10.1182/blood-2018-99-118834

Published: 2018

Journal Articles

DNA Methylation Identifies Genetically and Prognostically Distinct Subtypes of MDS

Brian M Reilly, BS, Tiffany N Tanaka, MD, Dinh Diep, PhD, Huwate Yeerna, BS, Pablo Tamayo, PhD, Kun Zhang, PhD, Rafael Bejar, MD PhD

Blood (2018) 132 (Supplement 1): 106.

https://doi.org/10.1182/blood-2018-99-111535

Published: 2018

Journal Articles

Methylation Profiling Among Patients with TET2 Mutations in Myelodysplastic Syndromes Is Associated with Overall Survival

Tiffany N Tanaka, MD, Brian Reilly, BS, Dinh Diep, BS, Kun Zhang, PhD, Rafael Bejar, MD PhD

Blood (2016) 128 (22): 3158.

https://doi.org/10.1182/blood.V128.22.3158.3158

Published: 2016

NARROW

Phenotypic and Proliferative Analysis of T Cell and Monocyte Populations in Patients with Intermediate/High/Very High-Risk MDS Compared to Age-Matched Healthy Donors

T Cell Activation By OKT3 Is a Function of the Percent Monocytes in PBMC of Healthy Donors and MDS Patients

A Phase 1 Clinical Trial of Personalized Adoptive Cellular Therapy Targeting Myelodysplastic Syndrome (MDS) Stem Cell Neoantigens (PACTN)

DNA Methylation Identifies Genetically and Prognostically Distinct Subtypes of MDS

Methylation Profiling Among Patients with TET2 Mutations in Myelodysplastic Syndromes Is Associated with Overall Survival

Email alerts

ASH Publications

American Society of Hematology

Phenotypic and Proliferative Analysis of T Cell and Monocyte Populations in Patients with Intermediate/High/Very High-Risk MDS Compared to Age-Matched Healthy Donors

T Cell Activation By OKT3 Is a Function of the Percent Monocytes in PBMC of Healthy Donors and MDS Patients

A Phase 1 Clinical Trial of Personalized Adoptive Cellular Therapy Targeting Myelodysplastic Syndrome (MDS) Stem Cell Neoantigens (PACTN)

DNA Methylation Identifies Genetically and Prognostically Distinct Subtypes of MDS

Methylation Profiling Among Patients with TET2 Mutations in Myelodysplastic Syndromes Is Associated with Overall Survival

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only